SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-11-003449
Filing Date
2011-11-10
Accepted
2011-11-10 09:01:23
Documents
10
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FROM 10-Q f10q_111011.htm 10-Q 367194
2 EXHIBIT 31.1 exh_311.htm EX-31.1 11932
3 EXHIBIT 31.2 exh_312.htm EX-31.2 11969
4 EXHIBIT 32 exh_32.htm EX-32 7343
  Complete submission text file 0001171843-11-003449.txt   1208417

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT caps-20110930.xml EX-101.INS 72236
6 XBRL TAXONOMY EXTENSION SCHEMA caps-20110930.xsd EX-101.SCH 11839
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE caps-20110930_cal.xml EX-101.CAL 18295
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE caps-20110930_def.xml EX-101.DEF 46511
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE caps-20110930_lab.xml EX-101.LAB 108718
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE caps-20110930_pre.xml EX-101.PRE 61830
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Filer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33560 | Film No.: 111193371
SIC: 2834 Pharmaceutical Preparations